HMR 3339, a novel selective estrogen receptor modulator, reduces concentrations of procarboxypeptidase U, an inhibitor of fibrinolysis. A randomized, placebo‐controlled study in postmenopausal women

Autor: Velja Mijatovic, Tatjana E. Vogelvang, M. J. Van Der Mooren, J. Willemse, Judith Leurs
Rok vydání: 2005
Předmět:
Zdroj: Journal of thrombosis and haemostasis
ISSN: 1538-7836
1538-7933
DOI: 10.1111/j.1538-7836.2005.01306.x
Databáze: OpenAIRE